LAUREN HOLLOWAY: Open Payments
NPI 1184181026 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 19 payments from 10 companies in 2025. Trend: 2023 $297 · 2024 $137 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $87 |
| Dendreon Pharmaceuticals LLC | 3 | $66 |
| UROGEN PHARMA, INC. | 3 | $63 |
| Procept Biorobotics Corporation | 2 | $62 |
| TOLMAR, INC. | 2 | $34 |
| Endo USA, Inc. | 1 | $32 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $21 |
| Medtronic, Inc. | 1 | $21 |
| COLOPLAST CORP | 1 | $16 |
| Antares Pharma, Inc. | 1 | $14 |
Products named: GEMTESA, PROVENGE, AQUABEAM ROBOTIC SYSTEM, XIAFLEX, JOURNAVX, INTERSTIM, JATENZO, SpeediCath.
Industry payments across OK — which companies pay providers there.
